MarketScreener Editorial Features Zealand Pharma A/S
Equities
ZEAL
DK0060257814
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 234.90 DKK | -36.38% |
|
-35.43% | -49.64% |
| 03-06 | Health Care Down, but not by Much, Amid Defensive Bias - Health Care Roundup | DJ |
| 03-06 | KBC Securities Downgrades Zealand Pharma to Accumulate, Cuts PT | MT |
MarketScreener Editorial Features
Search
 | Zealand Pharma suspends obesity project to focus on programs with greater potential | November 13, 2025 at 10:33 am |
 | Corporate results schedule for week of August 11, 2025 to August 15, 2025 | August 11, 2025 at 05:27 am |
 | Which way to go? | August 16, 2024 at 09:27 am |
 | Global markets live: Starbucks, J&J, On Holding, GM, Pandora... | August 13, 2024 at 11:51 am |
 | Would you like some more inflation? | June 28, 2024 at 08:56 am |
 | Global markets live: Robinhood, Dollar General, KKR, Boeing, Oracle... | March 14, 2024 at 01:15 pm |
| Zealand Pharma, a new competitor for Novo Nordisk? | January 24, 2024 at 10:14 am |
No results for this search
- Stock Market
- Equities
- ZEAL Stock
- News Zealand Pharma A/S
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition